MedTrace Logo

General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.

NCT00919126 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2014-09-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the quantity of propofol administered with Xenon in two inspiratory concentrations, to maintain comparable depth of anaesthesia during the maintenance period of general anaesthesia.

Conditions

  • Anaesthesia

Interventions

DRUG

Xenon

Maintenance of anaesthesia obtained with Xenon 50% and propofol infusion adjusted to depth of anaesthesia.

DRUG

Xenon

Maintenance of anaesthesia obtained with Xenon 70% and propofol infusion adjusted to depth of anaesthesia.

DRUG

Medical Air in Oxygen

Maintenance of anaesthesia obtained with propofol infusion adjusted to depth of anaesthesia.

Sponsors & Collaborators

  • Air Liquide SA

    lead INDUSTRY

Principal Investigators

  • Berthold BEIN, Prof Dr Med · University Hospital Schleswig-Holstein

  • Jens SCHOLZ, Prof. Dr Med · University Hospital Schleswig-Holstein

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • France
  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00919126 on ClinicalTrials.gov